Status:
COMPLETED
An Observational Study of Adjuvant Treatment With Capecitabine (Xeloda) in Combination With Oxaliplatin in Participants With Stage III Colon Cancer
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Colorectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This observational study evaluates the efficacy and safety of capecitabine in combination with oxaliplatin in the adjuvant setting in participants with Stage III colon cancer. Data were collected from...
Eligibility Criteria
Inclusion
- Adult participants, \>/= 18 years of age
- Treatment in line with the currently approved indication in the Summary of Product Characteristics
Exclusion
- Contraindications according to the current Summary of Product Characteristics
Key Trial Info
Start Date :
October 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
74 Patients enrolled
Trial Details
Trial ID
NCT01442155
Start Date
October 1 2011
End Date
April 1 2015
Last Update
July 7 2016
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Banská Bystrica, Slovakia, 975 17
2
Bratislava, Slovakia, 812 50
3
Bratislava, Slovakia, 833 10
4
Košice, Slovakia, 04001